Weight Loss Surgery Outshines GLP-1 Drugs in Preserving Kidney Health

Bariatric surgery may protect kidney function better than GLP-1 drugs in people with diabetes and obesity. This is according to a new study:

• The study looked at people who have obesity, diabetes and chronic kidney disease. It found that those who had bariatric surgery were less likely to have their kidney disease get worse compared to those who took GLP-1 Drugs.

• Chronic kidney disease often happens because of type 2 diabetes, which can be caused by obesity. This disease is a major reason why people with diabetes die.

• Bariatric surgery not only makes the stomach smaller, but it also causes changes in the body that reduce hunger.

A new study found that bariatric surgery is better at slowing down the progress of kidney disease in people with obesity and chronic kidney disease than GLP-1 diabetes drugs. The study showed that people who had bariatric surgery had a 60% lower chance of their kidney disease getting worse and a 44% lower chance of developing kidney failure or dying.

chronic kidney disease is as serious health issue for people with obesity and type 2 diabetes. It can lead to other health problems and death. One common type of bariatric surgery is called gastric sleeve surgery. In this surgery, about 80% of the stomach is removed. This makes people feel full faster when eating and also reduces hunger through changes in the body metabolism.

These changes help treat obesity, which is linked to both kidney disease and diabetes. The study included 425 people. Of those, 183 had surgery and 242 were treated with GLP-1 diabetes drugs, which also help with weight loss. The participants were followed for an average of 5.8 years.

The post Weight Loss Surgery Outshines GLP-1 Drugs in Preserving Kidney Health appeared first on GoMedii Blog.